Lymphangioleiomyomatosis — Trials

Lymphangioleiomyomatosis — Trials · CancerIndex

Clinical trials

Registered studies

42 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01552434	Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease	terminated	Phase 1	154	M.D. Anderson Cancer CenterOTHER	1	May 15, 2026	clinicaltrials
NCT02654340	Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)(TuScCom)	terminated	—	20	CENTOGENE GmbH RostockINDUSTRY	8	Feb 10, 2023